Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Roivant Sciences (ROIV) over the last 4 years, with Q3 2025 value amounting to $1.1 billion.

  • Roivant Sciences' Change in Acquisitions & Divestments changed N/A to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year change of. This contributed to the annual value of $2.0 billion for FY2025, which is N/A changed from last year.
  • Latest data reveals that Roivant Sciences reported Change in Acquisitions & Divestments of $1.1 billion as of Q3 2025.
  • In the past 5 years, Roivant Sciences' Change in Acquisitions & Divestments registered a high of $1.1 billion during Q3 2025, and its lowest value of $320.2 million during Q4 2021.
  • Over the past 3 years, Roivant Sciences' median Change in Acquisitions & Divestments value was $840.0 million (recorded in 2024), while the average stood at $776.3 million.
  • The largest annual percentage gain for Roivant Sciences' Change in Acquisitions & Divestments in the last 5 years was 20000.0% (2021), contrasted with its biggest fall of 20000.0% (2021).
  • Quarter analysis of 3 years shows Roivant Sciences' Change in Acquisitions & Divestments stood at $320.2 million in 2021, then soared by 199.84% to $960.0 million in 2024, then rose by 15.1% to $1.1 billion in 2025.
  • Its Change in Acquisitions & Divestments was $1.1 billion in Q3 2025, compared to $720.0 million in Q2 2025 and $960.0 million in Q4 2024.